Zenith Drugs Dividend
The Dividend of Zenith Drugs (ZENITHDRUG.NS) as of Nov 3, 2026 is 0.50 INR.
Get this data via API
Financial Data API
Dividend
0.50INR
Dividend yield
1.35 %
Last updated:
How much dividend does Zenith Drugs 2026 pay?
According to the latest status from November 2026, Zenith Drugs paid a total of 0.50 INR per share in dividends within the last 12 months. With the current Zenith Drugs price of 37.00 INR, this corresponds to a dividend yield of 1.35 %. A dividend is paid times per year.
At today's price the dividend yield works out to roughly 1.35%. The payout ratio is around 9% of earnings.
Historical Zenith Drugs Dividends
| Paydate | Dividend |
|---|---|
| 0.50INR |
The Zenith Drugs Dividend history
3 Years
10 Years
25 Years
Max
| YEAR | Dividend | YoY |
|---|---|---|
| 0.50INR | 0.00% | |
| 0.50INR | — | |
| 0.00INR | — |
Zenith Drugs dividend history and estimates
Max
Details
Is the Zenith Drugs Dividend Safe?
Zenith Drugs has been increasing the dividend for 0 years.
Analysts expect a Dividend Cut of -100.00% for the current fiscal year.
Zenith Drugs dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Dividend Details
Understanding Zenith Drugs's Dividend Distributions
Zenith Drugs’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Zenith Drugs's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Zenith Drugs's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Zenith Drugs’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Zenith Drugs Stock analysis
Frequently Asked Questions about Zenith Drugs stock
Over the past 12 months, Zenith Drugs paid a dividend of 0.50 INR . This corresponds to a dividend yield of about 1.35 %. For the coming 12 months, Zenith Drugs is expected to pay a dividend of 0.50 INR.
The current dividend yield of Zenith Drugs is 1.35 %.
Zenith Drugs paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0.50 INR are expected. This corresponds to a dividend yield of 1.35 %.
Zenith Drugs is assigned to the '—' sector.
To receive the latest dividend of Zenith Drugs from 10/25/2024 amounting to 0.5 INR, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.
The last dividend was paid out on 10/25/2024.
In the year 2025, Zenith Drugs distributed 0.5 INR as dividends.
The dividends of Zenith Drugs are distributed in INR.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
All Key Metrics — Zenith Drugs
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth